IsoRay Inc. (ISR) and Teleflex Incorporated (NYSE:TFX) Contrasting side by side

IsoRay Inc. (NYSEAMERICAN:ISR) and Teleflex Incorporated (NYSE:TFX) compete against each other in the Medical Instruments & Supplies sector. We will compare them and contrast their dividends, analyst recommendations, profitability, institutional ownership, risk, earnings and valuation.

Valuation & Earnings

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
IsoRay Inc. 6.27M 4.51 6.67M -0.12 0.00
Teleflex Incorporated 2.40B 5.39 66.07M 3.77 68.20

Table 1 shows the gross revenue, earnings per share (EPS) and valuation for IsoRay Inc. and Teleflex Incorporated.

Profitability

Table 2 shows IsoRay Inc. and Teleflex Incorporated’s return on equity, return on assets and net margins.

Net Margins Return on Equity Return on Assets
IsoRay Inc. -106.38% -87.2% -69.3%
Teleflex Incorporated 2.75% 2.7% 1.1%

Volatility & Risk

IsoRay Inc. has a 1.17 beta, while its volatility is 17.00% which is more volatile than S&P 500. Teleflex Incorporated’s 16.00% more volatile than S&P 500 volatility due to the stock’s 1.16 beta.

Liquidity

The current Quick Ratio of IsoRay Inc. is 6.6 while its Current Ratio is 6.9. Meanwhile, Teleflex Incorporated has a Current Ratio of 2.3 while its Quick Ratio is 1.5. IsoRay Inc. is better positioned to pay off its short-term and long-term debts than Teleflex Incorporated.

Dividends

The dividend yield for Teleflex Incorporated is 0.49% while its annual dividend payout is $1.36 per share. No dividend is paid out for IsoRay Inc.

Analyst Ratings

The Ratings and Recommendations for IsoRay Inc. and Teleflex Incorporated are featured in the next table.

Sell Ratings Hold Ratings Buy Ratings Rating Score
IsoRay Inc. 0 0 0 0.00
Teleflex Incorporated 0 1 3 2.75

Competitively the average target price of Teleflex Incorporated is $295.25, which is potential 4.85% upside.

Insider & Institutional Ownership

The shares of both IsoRay Inc. and Teleflex Incorporated are owned by institutional investors at 8.6% and 95.6% respectively. IsoRay Inc.’s share owned by insiders are 0.4%. Competitively, Teleflex Incorporated has 0.2% of it’s share owned by insiders.

Performance

Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
IsoRay Inc. -2.06% -15.84% -23.57% -10.89% -1.27% 1.43%
Teleflex Incorporated -6.63% -2.33% 1.74% -9.41% 2.38% 3.36%

For the past year IsoRay Inc. was less bullish than Teleflex Incorporated.

Summary

Teleflex Incorporated beats on 12 of the 13 factors IsoRay Inc.

IsoRay, Inc. develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma. It sells its products to facilities or physician practices that utilize multiple surgical facilities at which primarily prostate brachytherapy procedures are performed. The company was formerly known as Century Park Pictures Corporation and changed its name to IsoRay, Inc. in 2005. IsoRay, Inc. was founded in 1983 and is headquartered in Richland, Washington.

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products consisting of Arrow branded catheters and related devices for critical care therapies, including the administration of intravenous medications and other therapies, the measurement of blood pressure, and withdrawal of blood samples; interventional access products that are used in dialysis, oncology, and critical care therapies; and anesthesia products, such as airway management products under the LMA and Rusch brands, and pain management products under the Arrow brand. The company also provides surgical products, such as ligating clips and fascial closure systems; bladeless access ports, sutures, and other surgical instruments; and single-use and reusable products for surgical procedures under the Deknatel, Pilling, Kmedic, Hem-o-lok, and Weck brands. In addition, it offers medical devices for use in critical care, surgical, and cardiac care applications; and respiratory care products, such as oxygen therapy, aerosol therapy, spirometry, and ventilation management products under the Hudson RCI brand. Further, the company provides cardiac care products comprising diagnostic catheters; specialized catheters; therapeutic delivery catheters; sheaths for femoral and trans-radial aortic access, and intra-aortic balloons; and capital equipment, such as intra-aortic balloon pumps under the Arrow brand. Additionally, it provides catheters, urine collectors, catheterization accessories, and products for operative endourology under the Rusch brand name; micro-laparoscopic instrumentation products; and original equipment manufacturing services. The company offers its products to hospitals and healthcare providers through its direct sales force and distributors. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.